Key result
Myocardial stromal crosstalk with cardiomyocytes directly drives cardiac function and pathological remodeling.
Why the study?
The myocardial interstitium is now recognized as a dynamic neuro-immune-vascular niche critical for cardiac homeostasis and remodeling, but its structural and cellular organization and mechanisms of fibrosis and calcification require systematization.
Systematic Review
The myocardial interstitium functions as a dynamic, metabolically active niche where crosstalk between stromal cells and cardiomyocytes governs cardiac homeostasis and remodeling, highlighting the stroma as a crucial therapeutic target.
Introduction. A fundamental paradigm shift has occurred in modern cardiology: the myocardial interstitium (stroma) is no longer considered a passive scaffold, but a highly dynamic, metabolically active neuro-immune-vascular niche that maintains structural homeostasis, regulates electrophysiology and contractility, and determines the trajectory of pathological cardiac remodeling. Aim. To systematize current data on the structural and cellular organization of the myocardial stroma and to characterize the mechanisms of crosstalk between stromal elements and cardiomyocytes underlying fibrosis and ectopic calcification. Materials and Methods. A systematic review of PubMed/MEDLINE, Scopus, and Web of Science was performed; 48 of over 200 identified sources (2005–2026), predominantly from Q1-Q2 journals, were selected for analysis. Results. The myocardial architecture possesses a laminar spatial organization formed by collagen fibers of the endomysium and perimysium. The cellular composition of the interstitium is highly heterogeneous. Telocytes form a three-dimensional scaffold via telopodes, physically integrating tissue structures while stimulating cardiomyocyte maturation and maintaining regenerative potential through microRNA secretion. Pericytes control capillary blood flow — their pathological spasm underlies the “no-reflow” phenomenon during ischemia — and orchestrate regeneration through a secretome that stimulates neoangiogenesis and limits fibrosis. Cardiac fibroblasts govern matrix biosynthesis; their stepwise activation into myofibroblasts and matrifibrocytes drives replacement or reactive fibrosis, and fibroblast-derived TGF-β directly suppresses cardiomyocyte contractility. Beyond fibrosis, disrupted collagen turnover and ectopic stromal calcification (e.g., due to Fetuin-A deficiency) produce myocardial stiffness and diastolic dysfunction (HFpEF) refractory to pharmacological treatment. Conclusions. The physiological and pathological state of the heart depends entirely on bidirectional crosstalk between cardiomyocytes and the stroma; future cardiological and regenerative therapies must target the integrated multi-tissue microenvironment rather than the isolated cardiomyocyte.
No takes yet. Share an insight, caveat, or question.
Грабовий et al. (2026) conducted a systematic review in Myocardial fibrosis, stiffness, and ectopic stromal calcification. The myocardial stroma is a highly dynamic neuroimmune-vascular niche where crosstalk between stromal components and cardiomyocytes dictates both normal cardiac function and pathological remodeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: